MINT-CAPECITABINE TABLET 加拿大 - 英文 - Health Canada

mint-capecitabine tablet

mint pharmaceuticals inc - capecitabine - tablet - 500mg - capecitabine 500mg - antineoplastic agents

GEMCITABINE FOR INJECTION POWDER FOR SOLUTION 加拿大 - 英文 - Health Canada

gemcitabine for injection powder for solution

fresenius kabi canada ltd - gemcitabine (gemcitabine hydrochloride) - powder for solution - 200mg - gemcitabine (gemcitabine hydrochloride) 200mg - antineoplastic agents

GEMCITABINE FOR INJECTION POWDER FOR SOLUTION 加拿大 - 英文 - Health Canada

gemcitabine for injection powder for solution

fresenius kabi canada ltd - gemcitabine (gemcitabine hydrochloride) - powder for solution - 1g - gemcitabine (gemcitabine hydrochloride) 1g - antineoplastic agents

GEMCITABINE FOR INJECTION POWDER FOR SOLUTION 加拿大 - 英文 - Health Canada

gemcitabine for injection powder for solution

fresenius kabi canada ltd - gemcitabine (gemcitabine hydrochloride) - powder for solution - 2g - gemcitabine (gemcitabine hydrochloride) 2g - antineoplastic agents

Efavirenz/Emtricitabine/Tenofovir Disoproxil Clonmel 600 mg/200 mg/245 mg film-coated tablets 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

efavirenz/emtricitabine/tenofovir disoproxil clonmel 600 mg/200 mg/245 mg film-coated tablets

clonmel healthcare ltd - efavirenz; emtricitabine; tenofovir disoproxil - film-coated tablet - 600 mg/200 mg/245 milligram(s) - antivirals for treatment of hiv infections, combinations; emtricitabine, tenofovir disoproxil and efavirenz

Efavirenz/Emtricitabine/Tenofovir disoproxil Teva 600 mg/200 mg/245 mg Film-coated Tablets 马耳他 - 英文 - Medicines Authority

efavirenz/emtricitabine/tenofovir disoproxil teva 600 mg/200 mg/245 mg film-coated tablets

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - tenofovir disoproxil, efavirenz, emtricitabine - film-coated tablet - tenofovir disoproxil 245 mg efavirenz 600 mg emtricitabine 200 mg - antivirals for systemic use

Gemcitabine Ebewe 新西兰 - 英文 - Medsafe (Medicines Safety Authority)

gemcitabine ebewe

sandoz new zealand limited - gemcitabine hydrochloride 11.39 mg/ml equivalent to gemcitabine 10 mg/ml;   - concentrate for injection - 10 mg/ml - active: gemcitabine hydrochloride 11.39 mg/ml equivalent to gemcitabine 10 mg/ml   excipient: sodium acetate trihydrate sodium hydroxide water for injection - non-small cell lung cancer: gemcitabine ebewe, alone or in combination with cisplatin, is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer.

Gemcitabine Ebewe 新西兰 - 英文 - Medsafe (Medicines Safety Authority)

gemcitabine ebewe

novartis new zealand ltd - gemcitabine hydrochloride 228mg equivalent to 200 mg gemcitabine;  ;   - powder for injection - 200 mg - active: gemcitabine hydrochloride 228mg equivalent to 200 mg gemcitabine     excipient: mannitol nitrogen sodium acetate as sodium acetate trihydrate sodium hydroxide - non-small cell lung cancer: gemcitabine ebewe, alone or in combination with cisplatin, is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer.

Efavirenz/Emtricitabine/Tenofovir disoproxil Teva 600 mg/200 mg/245 mg Film-coated Tablets 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

efavirenz/emtricitabine/tenofovir disoproxil teva 600 mg/200 mg/245 mg film-coated tablets

teva b.v. - efavirenz; emtricitabine; tenofovir disoproxil - film-coated tablet - 600 mg/200 mg/245 milligram(s) - antivirals for treatment of hiv infections, combinations; emtricitabine, tenofovir disoproxil and efavirenz

Capecitabine Teva 欧盟 - 英文 - EMA (European Medicines Agency)

capecitabine teva

teva pharma b.v. - capecitabine - colonic neoplasms; breast neoplasms; colorectal neoplasms; stomach neoplasms - antineoplastic agents - capecitabine teva is indicated for the adjuvant treatment of patients following surgery of stage iii (dukes’ stage c) colon cancer.capecitabine teva is indicated for the treatment of metastatic colorectal cancer.capecitabine teva is indicated for first‑line treatment of advanced gastric cancer in combination with a platinum‑based regimen.capecitabine teva in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline. capecitabine teva is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.